Dynavax Technologies Corporation
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
 |
return to message board, top of board |
Today's presentation at Cantor Fitzgerald Global Healthcare ConferenceAt the presentation, Eddie mentioned that partner AstraZeneca just informed DVAX that top line data from AZD1419 result would be available later before the end of 2018 which confirmed AZD1419 trial was completed based on AZD1419 trial completion dates on 9/24/2018. Apparently, DVAX contacted AstraZeneca right after AZD1419 estimated completion date...
|
|
|
return to message board, top of board |
| Msg # | Subject | Author | Recs | Date Posted |
| 1239 | Re: Today's presentation at Cantor Fitzgerald Global Healthcare Conference | liuyiiv | 2 | 10/1/2018 2:05:43 PM |
